Compare Salesforce Inc (CRM) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Salesforce Inc vs Cronos Group Inc — how do they compare? Salesforce Inc trades at $198.4 (market cap $161.76B), while Cronos Group Inc trades at $3.05 (market cap $1.11B). The key difference: Salesforce Inc is far larger — about 145.7× Cronos Group Inc's market cap, and Salesforce Inc pays a 0.89% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRM | CRON | |
|---|---|---|
Market Cap | $161.76B | $1.11B |
Sector | Technology | Health |
52-Week High | $266.23 | $3.27 |
52-Week Low | $150.12 | $2.30 |
Enterprise Value | $191.81B | $310.67M |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Salesforce (CRM) trades at $197.52, up 2.48% today, with a bullish technical signal and strong fundamental performance. The stock shows consistent earnings beats, with Q1 2026 EPS of $3.88 exceeding the $3.13 estimate. Revenue growth is robust, reaching $37.90B in 2025, with a net income margin of 18.73%. Analyst consensus is strongly bullish with a $230.61 price target, supported by 75.78% buy ratings. Recent news highlights AI momentum and market volatility impacting software stocks.
The outlook for CRM is positive, driven by AI adoption and solid financials, but risks include sector-wide sell-offs and competitive pressures. The stock presents a growth opportunity with upside to the consensus target, though investors should monitor macroeconomic headwinds and execution risks in the evolving AI landscape.
CRON trades at $3.10 with a 0.98% daily gain, showing bullish technical momentum. The company delivered strong Q2 2026 results with 58% YoY revenue growth and earnings beat, while maintaining #1 market share in Canadian vapes and edibles. Despite negative net income in 2025, revenue growth accelerated to $147M with improving margins. Technical indicators show bullish moving averages but RSI suggests potential overbought conditions near $3 resistance.
Outlook remains positive with international expansion and European cannabis legalization driving growth, though competitive pressures and execution risks persist. Analyst consensus is mixed with 60% hold ratings, reflecting cautious optimism about CRON's turnaround trajectory from previous losses to projected 39% profit margin by 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
